Acute infantile hemorrhagic edema following measles mumps rubella vaccine: A case report

Erythema multiforme following live attenuated trivalent measles-mumps-rubella vaccine.

Acute hemorrhagic edema of infancy: A case report

Introduction: Acute hemorrhagic of infancy (AHEI) is a cutaneous leukocytoclastic vaculities that usually occurs in infants and young children that characterized by mild fever, hemorrhagic skin lesion, edema. It usually recovers spontaneously. Case Report: We describe a 11- months old boy with acute hemorrhagic edema of infancy with palpable erythematous rash on face, upper and lower limb...

Acute hemorrhagic edema of infancy: A case report

Acute hemorrhagic edema of infancy (AHEI) is a rare skin disorder which was first described by Snow in 1913. Clinical manifestations are usually limited to cutaneous lesions and is most commonly observed in infants under the age of 1 year. Usually, there is a history of recent upper respiratory tract infection and antibiotic administration. Clinical presentation of this disease includes petechi...

The Measles, Mumps, and Rubella (MMR) Vaccine

In 1971 Maurice Hillemanat at the Merck Institute of Therapeutic Research, a pharmaceutical company in West Point, Pennsylvania, created the measles, mumps, and rubella (MMR) vaccine. The vaccine combined three separate vaccines for measles, mumps, and rubella, common and sometimes fatal diseases. Measles causes a red skin rash and severe fevers that can be fatal. Mumps causes fever and swellin...

The Measles, Mumps, and Rubella (MMR) Vaccine

In 1971 Maurice Hillemanat at the Merck Institute of Therapeutic Research, a pharmaceutical company in West Point, Pennsylvania, created the measles, mumps, and rubella (MMR) vaccine. The vaccine combined three separate vaccines for measles, mumps, and rubella, common and sometimes fatal diseases. Measles causes a red skin rash and severe fevers that can be fatal. Mumps causes fever and swellin...